Evidence map›Paper›PMID 39856337›Full record

ArticleNature medicine2025

Author Correction: Propagative α-synuclein seeds as serum biomarkers for synucleinopathies.

Ayami Okuzumi, Taku Hatano, Gen Matsumoto, Shuko Nojiri, Shin-Ichi Ueno, Yoko Imamichi-Tatano, Haruka Kimura, Soichiro Kakuta, Akihide Kondo, Takeshi Fukuhara and 12 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Ayami OkuzumiDepartment of Neurology, Juntendo University Faculty of Medicine, Tokyo, Japan.ORCID http://orcid.org/0000-0001-8044-5402
Taku HatanoDepartment of Neurology, Juntendo University Faculty of Medicine, Tokyo, Japan.ORCID http://orcid.org/0000-0002-6808-0444
Gen MatsumotoDepartment of Histology and Cell Biology, Nagasaki University School of Medicine, Nagasaki, Japan.
Shuko NojiriMedical Technology Innovation Center, Juntendo University Faculty of Medicine, Tokyo, Japan.
Shin-Ichi UenoDepartment of Neurology, Juntendo University Faculty of Medicine, Tokyo, Japan.ORCID http://orcid.org/0000-0003-4133-3605
Yoko Imamichi-TatanoDepartment of Neurology, Juntendo University Faculty of Medicine, Tokyo, Japan.ORCID http://orcid.org/0000-0001-6830-456X
Haruka KimuraDepartment of Neurology, Juntendo University Faculty of Medicine, Tokyo, Japan.ORCID http://orcid.org/0009-0004-2632-1352
Soichiro KakutaLaboratory of Morphology and Image Analysis, Biomedical Research Core Facilities, Juntendo University Faculty of Medicine, Tokyo, Japan.ORCID http://orcid.org/0000-0001-9434-4944
Akihide KondoDepartment of Neurosurgery, Juntendo University Faculty of Medicine, Tokyo, Japan.ORCID http://orcid.org/0000-0003-1729-4490
Takeshi FukuharaNeurodegenerative Disorders Collaboration Laboratory, RIKEN Center for Brain Science, Saitama, Japan.
Yuanzhe LiDepartment of Neurology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Manabu FunayamaDepartment of Neurology, Juntendo University Faculty of Medicine, Tokyo, Japan.ORCID http://orcid.org/0000-0002-7412-3631
Shinji SaikiDepartment of Neurology, Juntendo University Faculty of Medicine, Tokyo, Japan.ORCID http://orcid.org/0000-0002-9732-8488
Daisuke TaniguchiDepartment of Neurology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Taiji TsunemiDepartment of Neurology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Deborah McIntyreTransversal Translational Medicine, Luxembourg Institute of Health (LIH), Strassen, Luxembourg.
Jean-Jacques GérardyLuxembourg National Center of Pathology (NCP), Laboratoire National de Santé (LNS); Department of Cancer Research (DOCR), Luxembourg Institute of Health (LIH); Luxembourg Centre of Neuropathology (LCNP), Luxembourg Centre for Systems Biomedicine (LCSB), Faculty of Science, Technology and Medicine (FSTM) and Department of Life Sciences and Medicine (DLSM), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
Michel MittelbronnLuxembourg National Center of Pathology (NCP), Laboratoire National de Santé (LNS); Department of Cancer Research (DOCR), Luxembourg Institute of Health (LIH); Luxembourg Centre of Neuropathology (LCNP), Luxembourg Centre for Systems Biomedicine (LCSB), Faculty of Science, Technology and Medicine (FSTM) and Department of Life Sciences and Medicine (DLSM), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
Rejko KrugerTransversal Translational Medicine, Luxembourg Institute of Health (LIH), Strassen, Luxembourg.
Yasuo UchiyamaDepartment of Cellular and Molecular Neuropathology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Nobuyuki NukinaLaboratory of Structural Neuropathology, Graduate School of Brain Science, Doshisha University, Kyoto, Japan.
Nobutaka HattoriDepartment of Neurology, Juntendo University Faculty of Medicine, Tokyo, Japan. nhattori@juntendo.ac.jp.ORCID http://orcid.org/0000-0002-2034-2556

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39856337
PMCPMC11835715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.